A Phase 1 Study of S-3304 in Patients With Solid Tumors
NCT00033215
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
S-3304
Sponsor
Shionogi